UF-KURE-BCMA CAR-T Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for UF-KURE-BCMA CAR-T Cells, covering 2025-09-23 to 2025-09-23. Get the full timeline:
Most recent: Clinical Trial Update: UF-KURE-BCMA CAR-T Cells in Patients With Relapsed or Refractory Multiple Myeloma [Phase 1]